A Randomized Phase III Study Comparing Adjuvant 5-fluorouracil/Folinic Acid with FOLFIRI in Patients Following Complete Resection of Liver Metastases from Colorectal Cancer
Abstract Background: Studies indicate that adjuvant 5-fluorouracil (5-FU) with folinic acid (FA) in colorectal cancer patients with completely resectable liver-limited metastases (LMCRC) offers clinical benefit over surgery alone. This phase III trial compared FOLFIRI with simplified 5-FU/FA in this setting. Patients and methods: LMCRC patients were randomized to receive every 14 days, FA, 400 mg/m2 [...]

